Texas 2023 - 88th Regular

Texas House Bill HB1313 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New	Differences
1	1	By: Burrows H.B. No. 1313
2	2
3	3
4	4	A BILL TO BE ENTITLED
5	5	AN ACT
6	6	relating to a study on the side effects, adverse reactions,
7	7	including death, and the effectiveness of vaccines against the
8	8	SARS-CoV-2 virus (COVID-19) or its variants.
9	9	BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
10	10	SECTION 1. (a) In this section:
11	11	(1) "Commission" means the Health and Human Services
12	12	Commission.
13	13	(2) "Executive commissioner" means the executive
14	14	commissioner of the Health and Human Services Commission.
15	15	(3) "Department" means the Department of State Health
16	16	Services.
17	17	(4) "COVID 19" means the SARS-CoV-2 virus and any of
18	18	its variants.
19	19	(5) "Vaccine" means a substance used to stimulate
20	20	immunity to a particular infectious disease or pathogen, typically
21	21	prepared from an inactivated or weakened form of the causative
22	22	agent or from its constituents or products.
23	23	(b) The Commission in collaboration with the Department
24	24	shall conduct a study to assess the full and complete adverse
25	25	reactions, including death, and effectiveness of each type of
26	26	vaccine used in Texas to defend the human body against "COVID 19.
27	27	The Report must include:
28	28	(1) The immediate short-term side effects and adverse
29	29	reactions recipients experienced from taking the various Covid-19
30	30	vaccines used in Texas; including but not limited to include:
31	31	i. Pain, swelling, or redness where the shot was
32	32	given
33	33	ii. Mild fever
34	34	iii. Chills
35	35	iv. Feeling tired
36	36	v. Headache
37	37	vi. Muscle and joint aches
38	38	(2) The immediate serious side effects and adverse
39	39	reactions recipients experienced from taking the various Covid-19
40	40	vaccines used in Texas; including but not limited to include:
41	41	i. difficulty breathing;
42	42	ii. swelling of the face and throat;
43	43	iii. accelerated heartbeat;
44	44	iv. a body rash;
45	45	v. dizziness; and
46	46	vi. weakness
47	47	(3) Any long-term side effects and adverse reactions
48	48	recipients have experienced from taking the various Covid-19
49	49	vaccines used in Texas; including but not limited to include:
50	50	i. paralysis;
51	51	ii. Myocarditis;
52	52	iii. clotting disorders;
53	53	iv. Thrombosis with Thrombocytopenia Syndrome
54	54	(TTS);
55	55	v. Guillain-Barré syndrome (GBS);
56	56	vi. difficulty thinking or "brain fog,"
57	57	vii. chronic pain;
58	58	viii. tiredness and fatigue;
59	59	ix. loss of taste;
60	60	x. depression;
61	61	xi. anxiety; and
62	62	xii. death.
63	63	(4) Any misrepresentations about the effectiveness or
64	64	dangers of taking of the vaccine by its manufacturers or any
65	65	governmental agency; and,
66	66	(5) Any concealment of information about the
67	67	effectiveness or dangers of taking of the vaccine by its
68	68	manufacturers or any governmental agency.
69	69	(c) The Commission and the Department shall gather
70	70	information for the report from:
71	71	(1) information collected by the Commission and the
72	72	Department, including information from the department's vital
73	73	statistics unit and the state Medicaid program; and
74	74	(2) hospitals, treatment centers, available surveys,
75	75	(3) and other relevant sources.
76	76	SECTION 2. (a) Not later than January 1, 2024, the
77	77	Commission and Department shall prepare and submit to the Governor,
78	78	Lieutenant Governor, the Speaker of the House of Representatives,
79	79	and the Chairpersons of the relevant Texas legislative committees
80	80	with jurisdiction over the Commission and the Department, a copy of
81	81	the report, summary of any findings, and any recommendations for
82	82	legislative or executive action to reduce the prevalence of
83	83	COVID-19 Vaccine side effects. The department may post the report
84	84	on the department's Internet website.
85	85	(b) The Commission and Department may accept gifts, grants,
86	86	and donations from any source to fund expenses incurred by the
87	87	Commission and the Department in preparing the report.
88	88	SECTION 3. This Act expires September 1, 2025.
89	89	SECTION 4. This Act takes effect immediately if it receives
90	90	a vote of two-thirds of all the members elected to each house, as
91	91	provided by Section 39, Article III, Texas Constitution. If this
92	92	Act does not receive the vote necessary for immediate effect, this
93	93	Act takes effect September 1, 2023.